Research Partnership Launches 'Living With' Reports

Healthcare specialist Research Partnership has published two new patient syndicated reports: Living With Ulcerative Colitis (UC) and Living With Crohn's Disease (CD).

The London-based firm, which also has offices in Boston, Philadelphia, San Francisco, New York, Singapore and Lyon, specialises in supplying primary qual and quant market research and consulting services to the sector. It also offers RP Therapy Watch, collecting data from an online community of specialist physicians across the globe so clients can monitor their market and competitors in real time.

According to the firm, its new reports offer insights into patient attitudes and behaviour towards their condition, treatments, and unmet needs; and they also include topics such as treatment switching behaviour and sub-analysis of patient groups according to treatment. Living with UC covers three regions: the 5EU (the UK, France, Germany, Italy and Spain - a sample of 270 patients), the US (106 patients) and Japan (56 patients); while Living with CD covers two regions: the 5EU (266 patients) and Japan (55 patients). For both reports, the methodologies comprise 30-minute quant online interviews and a small sample of 30-minute qual telephone interviews. Both 5EU reports also include a patient segmentation analysis based on attitudinal and behavioural drivers.

Mariel Metcalfe, Head of Living With, comments: 'Research Partnership is committed to producing research which focuses on the voice of the patient, and to offer a more patient-centric view of what it is like to live with a long-term, life-changing illness. Our reports cover a wide range of therapy areas from autoimmune, dermatology and gastroenterology, and we hope to expand the list of therapy areas year on year'.

Web site: www.researchpartnership.com .